Key Details
Price
$34.59Annual ROE
-9.97%Beta
2.01Events Calendar
Next earnings date:
Mar 25, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 25, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 10, 2019Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
OsStic ® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually ( 1) ; arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year
FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company's Chairman and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference, which is being held at The Lotte New York Palace in New York, NY from December 3 – 5, 2024. Mr. Nixon will deliver a presentation to investors on Wednesday, December 4 at approximately 11:50 a.m. Eastern Time.
Sanara MedTech (SMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Michael McNeil - Chief Financial Officer Sam Muppalla - Tissue Health Plus Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCapClub Chris Plahm - Tall Pines Capital John Siedhoff - Twin Oaks Equity Operator Good morning, and welcome to the Sanara MedTech Third Quarter 2024 Earnings Conference Call. The company issued its earnings release yesterday and will post today's supplemental deck on the Investor Relations page on the company's website.
FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara will issue its earnings release on Tuesday, November 12, 2024, and will host a conference call on Wednesday, November 13, 2024, at 9:00 a.m.
FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director, and Mr. Keith Myers has been appointed to serve as a director on the Board in order to fill the vacancy resulting from Mr. Stuckert's resignation. Mr. Stuckert will continue to serve the Board as Director Emeritus.
Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2024 Earnings Conference Call on May 14, 2024 at 9:00 AM ET with company representatives Callon Nichols, Ron Nixon, Mike McNeil, and Seth Yon. Moderator Ian Cassel from IFCM Operator. Welcome to the Sanara MedTech Inc. First Quarter Results and Business Update Conference Call. All participants are currently in a listen-only mode.
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2023 Results Conference Call November 14, 2023 9:00 AM ET Company Participants Callon Nichols - Vice President of Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - Chief Executive Officer Mike McNeil - CFO & Corporate Secretary Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - IFCM Niraj Gupta - GCI Partners Operator Greetings, and welcome to the Sanara MedTech Incorporated Third Quarter 2023 Results and Business Update Call. At this time, all participants are in a listen-only mode.
Sanara Medtech, Inc. (NASDAQ:SMTI ) Q2 2023 Earnings Conference Call August 15, 2023 9:00 AM ET Company Participants Callon Nichols - VP, Corporate Operations Ron Nixon - Executive Chairman Zach Fleming - CEO Mike McNeil - CFO Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCap Club Operator Greetings. Welcome to the Sanara MedTech Inc. Second Quarter 2023 Results and Business Update Conference Call.
FAQ
- What is the ticker symbol for Sanara MedTech?
- Does Sanara MedTech pay dividends?
- What sector is Sanara MedTech in?
- What industry is Sanara MedTech in?
- What country is Sanara MedTech based in?
- When did Sanara MedTech go public?
- Is Sanara MedTech in the S&P 500?
- Is Sanara MedTech in the NASDAQ 100?
- Is Sanara MedTech in the Dow Jones?
- When was Sanara MedTech's last earnings report?
- When does Sanara MedTech report earnings?
- Should I buy Sanara MedTech stock now?